Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Helocyte
AddedFeb 15, 2024
UpdatedJun 18, 2026
Helocyte

Helocyte

Public

Helocyte: Developing and commercializing novel immunotherapies for cancer and infectious diseases.

HQ
New York City, NY, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Helocyte, founded by Fortress Biotech, Inc., is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel immunotherapies aimed at preventing and treating cancer and infectious diseases, particularly cytomegalovirus (CMV). The company's core mission is to harness the power of the immune system to combat these severe health challenges. Helocyte's product pipeline includes innovative therapies like CMV Triplex and ConVax, targeting both oncology and infectious disease markets.

Notable figures affiliated with Helocyte include its experienced management team and a distinguished scientific advisory board. The company has achieved significant milestones in advancing its clinical trials and securing strategic partnerships. Helocyte's impact lies in its potential to revolutionize treatment paradigms for cancer and CMV, offering hope for improved patient outcomes through cutting-edge immunotherapy solutions.

Helocyte - Similar Companies

HebeCell logo

HebeCell

hebecellcorp.com

Cellular Approaches logo

Cellular Approaches

Cel-Sci logo

Cel-Sci

cel-sci.com

HCW Biologics logo

HCW Biologics

hcwbiologics.com

Helomics logo

Helomics

Cellerant Therapeutics logo

Cellerant Therapeutics

Celularity logo

Celularity

celularity.com

HI-Bio logo

HI-Bio

hibio.com

Bellicum Pharmaceuticals logo

Bellicum Pharmaceuticals

OmniCyte logo

OmniCyte

omnicyte.com

Immunaeon logo

Immunaeon

immunaeon.com

Helicon Therapeutics logo

Helicon Therapeutics

ImmunityBio logo

ImmunityBio

immunitybio.com

CytoAgents logo

CytoAgents

cytoagents.com

Kincell Bio logo

Kincell Bio

kincellbio.com

Helocyte - Quick Facts

Who are Helocyte's competitors?

Companies similar to Helocyte include HebeCell, Cellular Approaches, Cel-Sci and HCW Biologics.

When was Helocyte founded?

Helocyte was founded in 2015.

Where is Helocyte's headquarters located?

Helocyte's headquarters is located in New York City, NY, US.

When was Helocyte's last funding round?

Helocyte's most recent funding round was for $3.2M (USD) in June 2023.

How much has Helocyte raised to-date?

As of Jun 15, 2023, Helocyte has raised a total of $8.2M (USD).

How many employees does Helocyte have?

Helocyte has 6 employees as of Feb 5, 2024.

Helocyte - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Immunotherapies
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified